Median IL-6 serum levels were significantly higher in SSc patients compared to HC [10.81 pg/ml (IQR 3.35–27.36) vs. 5.92 pg/ml (IQR 4.80–6.58), p < 0.05] (Fig. 1E). Here, IL6 is linked to systemic sclerosis.